Human Gene Sequencing Markets, Strategies & Trends: Forecasts By Application, By Technology, By Workflow, By Product, and By Country with Executive and Consultant Guides

1.1 Human Gene Sequencing Markets - Strategic Situation Analysis
1.2 Guide for Executives, Marketing, Sales, and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors

2.1 Gene Sequencing Definition In This Report
2.1.1 Gene Sequencing
2.1.2 Hereditary
2.1.3 Non-Invasive Prenatal Testing
2.1.4 Oncology
2.1.5 Psychology
2.1.6 WGES
2.1.7 Pharmacogenomic
2.1.8 Direct-to-Consumer
2.1.9 Research
2.1.10 Other
2.2 The Genomics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.4 Methodology
2.4.1 Methodology
2.4.2 Sources
2.4.3 Authors
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
2.6 Chromosomes, Genes and Epigenetics
2.6.1 Chromosomes
2.6.2 Genes
2.6.3 Epigenetics
2.6.4 Genetic Testing vs. Gene Sequencing
2.6.5 Cost and Pricing Practice

3.1 Notes to Installed Base Listing
3.2 Illumina Installed Base

4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Chemical/Reagent Supplier
4.1.5 Pathology Supplier
4.1.6 Independent Clinical Laboratory
4.1.7 Public National/regional Laboratory
4.1.8 Hospital Laboratory
4.1.9 Physicians Office Lab (POLS)
4.1.10 Audit Body
4.1.11 Certification Body
4.2 Human Gene Sequencing -Markets, Examples and Discussion
4.2.1 Inherited Disease - Not what it used to be
4.2.1.1 Clinical and Research Lines Blur
4.2.1.2 Genetic Counselling - Not so simple anymore
4.2.1.3 The Genetic Blizzard - Issues of Access and Payment
4.2.2 Newborn Screening - The Standard of Care
4.2.2.1 Newborn Screening - Do Parents Want to Know?
4.2.3 NIPT - We’ve Only Just Begun
4.2.3.1 NIPT, IVF, and the Fertility Practice - PGS, PGD, CCS
4.2.3.2 NIPT in the Future - Beyond Inherited Disease
4.2.4 Oncology - Understanding Two Worlds
4.2.4.1 The Tumor - A Sequence of Sequencing
4.2.4.2 The Tumor - Biopsy and Liquid Biopsy
4.2.4.3 The Human Genome - Predisposition and Prognosis
4.2.5 Pharmacogenomics
4.2.5.1 Sequencing Not the Only Player
4.2.5.2 New Roles for Old Drugs - A Research Bonanza?
4.2.6 Direct To Consumer - More Than Meets the Eye
4.2.6.1 DTC - How Many Segments?
4.3 Industry Structure
4.3.1 Hospital’s Testing Share
4.3.2 The Rise of the Sequencing Lab
4.3.3 Sequencing as a Commodity
4.3.4 Informatics
4.3.5 Instrument Manufacturer Role
4.3.6 Healthcare Industry Impacts - Still Struggling
4.3.7 Can the Healthcare Industry Adapt?
4.3.8 Genetic Counselling as an Industry
4.3.9 Sequencing Adoption and Cannibalization

5.1 Factors Driving Growth
5.1.1 New Diagnoses
5.1.2 Wellness and Prevention
5.1.3 Fertility Technology
5.1.4 Cancer - Screening, Management and Monitoring
5.2 Factors Limiting Growth
5.2.1 Increased Competition Lowers Price
5.2.2 Lower Costs
5.2.3 Healthcare Cost Concerns Curtail Growth
5.2.4 Wellness has a downside
5.3 Sequencing Instrumentation
5.3.1 Instrumentation Tenacity
5.3.2 Declining Cost of Instruments Changes Industry Structure
5.3.3 Long Reads - Further Segmentation
5.3.4 Linked Reads
5.3.5 New Sequencing Technologies

6.1 Recent Developments - Importance and How to Use This Section
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 WGS Improves Pediatric Cancer Care
6.3 Cancer genomes identify candidate driver genes
6.4 Genetic Dx a game changer
6.5 Nonacus Galeas Tumor
6.6 Lucence LiquidHallmark Assay Gets Coverage
6.7 Garvan Institute Gets Gramt to Develop Genomics Tests
6.8 Arima Genomics, Protean BioDiagnostics Launch Joint Venture
6.9 Geneseeq Nabs CE Marks for Cancer Test Kits
6.10 Viome Life Sciences Announces Gut Intelligence Test
6.11 Quest Diagnostics Announces Genetic Insights
6.12 Exact Sciences Releases Next-Gen Cologuard
6.13 BGI Genomics Forges Partnerships in Latin America
6.14 4bases Bets on NGS Diagnostics
6.15 Guardant Health Submits Colorectal Cancer Screening Test
6.16 Universal DX Eyeing Approval for Colorectal Cancer Screening Test
6.17 Natera Files Suit Against NeoGenomics
6.18 Genomics England to Sequence 100K Newborns
6.19 Novigenix Raises $14M for NGS based Liquid Biopsy
6.20 LetsGetChecked Launching New PGx Service
6.21 Qiagen, Neuron23 Partner for NGS Diagnostic
6.22 Harbinger Health Technology Focused On Oncogenesis
6.23 Delfi Diagnostics to Develop Early Detection Test
6.24 Dante Labs to Introduce WGS to Italian Healthcare System
6.25 Invitae Neurodevelopmental Disorders Testing Service
6.26 Thermo Fisher Obtains CE Mark for Ion Torrent Genexus
6.27 Myriad Genetics Launches Suite of Cancer Tests
6.28 Oncocyte and Thermo Fisher Strike Partnership Deal
6.29 Illumina Partners With Precision Medicine to Assess Liquid Biopsy
6.30 Sysmex Inostics Develops Ultra-Sensitive Liquid Biopsy
6.31 Twist Bioscience, Centogene Partner on NGS-Based Rare Disease Testing
6.32 Strata Oncology Trial Supports NGS Assay
6.33 NYU Gets FDA Clearance for Sequencing Test
6.34 NeoGenomics to Acquire Inivata
6.35 OncoDNA, Institut Curie Partner on Liquid Biopsy Research
6.36 Cancer Heritability Gene Set Expanded
6.37 Whole-Genome Sequencing Could Replace Cytogenetics
6.38 Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays
6.39 Ancestry Shutters Health Offering
6.40 Genetron Health Targeting Early Cancer Detection
6.41 Pan-European Initiative to Build Tools for Sharing Genomic Data
6.42 UK Government Unveils New Genomic Healthcare Strategy
6.43 Foundation Medicine Liquid Biopsy Gets FDA Approval
6.44 American Heart Association Develops Genetic Testing Guidelines
6.45 Yourgene Health Gets CE Mark for Iona NIPT Test
6.46 NorthShore Looks to Expand Genomics Integration Into Primary Care
6.47 Germline Results From Tumor Sequencing Guides Precision Therapy
6.48 FDA Clears Cancer Genomic Profiling From Personal Genome Diagnostics 334
6.49 BillionToOne Closes $15M Series A Follow-on Round
6.50 Clinics to Integrate Genomics Into Primary Care

7.1 10x Genomics, Inc.
7.2 23andME Inc.
7.3 Abbott Laboratories
7.4 AccuraGen Inc.
7.5 Adaptive Biotechnologies
7.6 Admera Health, LLC
7.7 Advanced Biological Laboratories
7.8 Agilent
7.9 Akonni Biosystems
7.10 Amoy Diagnostics Co., Ltd.
7.11 Ancestry.com LLC
7.12 Anchor Dx
7.13 Arrayit Corporation
7.14 ARUP Laboratories
7.15 Astrid Bio
7.16 Azenta
7.17 BaseClear
7.18 Baylor Miraca Genetics Laboratories
7.19 Beckman Coulter Diagnostics (Danaher)
7.20 Becton, Dickinson and Company
7.21 BGI Genomics Co. Ltd
7.22 Bioarray Genetics
7.23 BioBam
7.24 Biocept, Inc.
7.25 Biodesix Inc.
7.26 BioFluidica
7.27 BioGenex
7.28 Biolidics Ltd
7.29 bioMérieux Diagnostics
7.30 Bioneer Corporation
7.31 Bio-Rad Laboratories, Inc.
7.32 Bio-Techne
7.33 Burning Rock
7.34 C2i Genomics
7.35 Cantata Bio
7.36 CareDx
7.37 Caris Molecular Diagnostics
7.38 Celemics
7.39 CellMax Life
7.40 Centogene
7.41 Cepheid (Danaher)
7.42 Circulogene
7.43 Clearbridge Biomedics
7.44 Clinical Genomics
7.45 Color Genomics
7.46 Complete Genomics (MGI Tech)
7.47 CosmosID
7.48 Dante Labs
7.49 Datar Cancer Genetics Limited
7.50 Diasorin S.p.A.
7.51 Easy DNA
7.52 Element Biosciences
7.53 Epic Sciences
7.54 Epigenomics AG
7.55 Eurofins Scientific
7.56 Excellerate Bioscience
7.57 Fabric Genomics
7.58 Freenome
7.59 FUJIFILM Wako Diagnostics
7.60 Fujirebio
7.61 Fulgent Genetics
7.62 GE Global Research
7.63 Gene by Gene, Ltd.
7.64 Genedrive
7.65 GeneDx Holdings
7.66 GeneFirst Ltd.
7.67 GeneFluidics
7.68 Genetron Holdings
7.69 Genewiz
7.70 Genomics England
7.71 Genomics Personalized Health (GPH)
7.72 GenomOncology
7.73 Genzyme Corporation
7.74 Grifols
7.75 Guardant Health
7.76 Guardiome
7.77 Helix
7.78 Hologic
7.79 HTG Molecular Diagnostics
7.80 Human Longevity, Inc.
7.81 iCellate
7.82 Illumina
7.83 Incell Dx
7.84 Inivata
7.85 Invitae Corporation
7.86 Invivoscribe
7.87 Karius
7.88 Letsgetchecked
7.89 Lucence Health
7.90 Lunglife AI Inc
7.91 Macrogen
7.92 MDNA Life SCIENCES, Inc.
7.93 MDx Health
7.94 Medgenome
7.95 Meridian Bioscience
7.96 Mesa Laboratories, Inc.
7.97 Metabiomics Corp
7.98 miR Scientific
7.99 NantHealth, Inc.
7.100 Natera
7.101 Nebula Genomics
7.102 NeoGenomics
7.103 New England Biolabs, Inc.
7.104 NGeneBio
7.105 Norgen Biotek Corp.
7.106 Novogene
7.107 Omega Bioservices
7.108 Oncocyte
7.109 OncoDNA
7.110 OpGen
7.111 Origene Technologies
7.112 Oxford Nanopore Technologies
7.113 Pacific Biosciences
7.114 Panagene
7.115 PathoQuest S.A.
7.116 Personalis
7.117 PGDx (Labcorp)
7.118 Precipio
7.119 PrecisionMed
7.120 Predictive Oncology
7.121 Promega
7.122 Qiagen
7.123 QuantuMDx
7.124 Regeneron Pharmaceuticals
7.125 Revvity
7.126 Roche Diagnostics
7.127 Roswell Biotechnologies
7.128 Seegene
7.129 SeLux Diagnostics
7.130 Sequencing.com
7.131 Siemens Healthineers
7.132 simfo GmbH
7.133 Singlera Genomics Inc.
7.134 Singular Genomics
7.135 SkylineDx
7.136 Standard BioTools
7.137 Sysmex
7.138 Sysmex Inostics
7.139 Tempus Labs, Inc.
7.140 Thermo Fisher Scientific
7.141 Ultima Genomics
7.142 Unchained Labs
7.143 Variantyx
7.144 Vela Diagnostics
7.145 VolitionRX
7.146 Zymo Research Corp

8.1 Global Market Overview by Country
8.1.1 Table - Global Market by Country
8.1.2 Chart - Global Market by Country
8.2 Global Market by Application - Overview
8.2.1 Table - Global Market by Application
8.2.2 Chart - Global Market by Application - Base/Final Year Comparison
8.2.3 Chart - Global Market by Application - Base Year
8.2.4 Chart - Global Market by Application - Final Year
8.2.5 Chart - Global Market by Application - Share by Year
8.2.6 Chart - Global Market by Application - Segment Growth
8.3 Global Market by Technology - Overview
8.3.1 Table - Global Market by Technology
8.3.2 Chart - Global Market by Technology - Base/Final Year Comparison
8.3.3 Chart - Global Market by Technology - Base Year
8.3.4 Chart - Global Market by Technology - Final Year
8.3.5 Chart - Global Market by Technology - Share by Year
8.3.6 Chart - Global Market by Technology - Segment Growth
8.4 Global Market by Workflow - Overview
8.4.1 Table - Global Market by Workflow
8.4.2 Chart - Global Market by Workflow - Base/Final Year Comparison
8.4.3 Chart - Global Market by Workflow - Base Year
8.4.4 Chart - Global Market by Workflow - Final Year
8.4.5 Chart - Global Market by Workflow - Share by Year
8.4.6 Chart - Global Market by Workflow - Segment Growth
8.5 Global Market by Product - Overview
8.5.1 Table - Global Market by Product
8.5.2 Chart - Global Market by Product - Base/Final Year Comparison
8.5.3 Chart - Global Market by Product - Base Year
8.5.4 Chart - Global Market by Product - Final Year
8.5.5 Chart - Global Market by Product - Share by Year
8.5.6 Chart - Global Market by Product - Segment Growth

9.1 Hereditary Gene Sequencing Market
9.1.1 Table - Hereditary by Country
9.1.2 Chart - Hereditary Segment Growth
9.2 NIPT Gene Sequencing Market
9.2.1 Table NIPT by Country
9.2.2 Chart - NIPT Growth
9.3 Oncology Market
9.3.1 Table - Oncology by Country
9.3.2 Chart - Oncology Growth
9.4 Psychology Market
9.4.1 Table - Psychology by Country
9.4.2 Chart - Psychology Growth
9.5 WGES Gene Sequencing Market
9.5.1 Table - WGES by Country
9.5.2 Chart - WGES growth
9.6 Pharmacogenomics Market
9.6.1 Table Pharmacogenomics by Country
9.6.2 Chart - Pharmacogenomics Growth
9.7 DTC Gene Sequencing Market
9.7.1 Table - DTC by Country
9.7.2 Chart - DTC Growth
9.8 Research Gene Sequencing Market
9.8.1 Table - Research by Country
9.8.2 Chart - Research Growth
9.9 Other Application Market
9.9.1 Table - Other Application by Country
9.9.2 Chart - Other Application growth

10.1 Sanger Sequencing Market
10.1.1 Table - Sanger by Country
10.1.2 Chart - Sanger Segment Growth
10.2 NGS/2G Market
10.2.1 Table NGS/2G by Country
10.2.2 Chart - NGS/2G Growth
10.3 3G/Long Market
10.3.1 Table - 3G/Long by Country
10.3.2 Chart - 3G/Long Growth
10.4 Other Technology Market
10.4.1 Table - Other Technology by Country
10.4.2 Chart - Other Technology Growth

11.1 Sequencing Market
11.1.1 Table - Sequencing by Country
11.1.2 Chart - Sequencing Segment Growth
11.2 Sample Prep Market
11.2.1 Table Sample Prep by Country
11.2.2 Chart - Sample Prep Growth
11.3 Analysis Market
11.3.1 Table - Analysis by Country
11.3.2 Chart - Analysis Growth

12.1 Instruments Market
12.1.1 Table - Instruments by Country
12.1.2 Chart - Instruments Segment Growth
12.2 Consumables Market
12.2.1 Table Consumables by Country
12.2.2 Chart - Consumables Growth
12.3 Software & Services Market
12.3.1 Table - Software & Services by Country
12.3.2 Chart - Software & Services Growth

14.1 Growth of Approved IVD Test Menu
14.2 Growth of Approved Average IVD Test Fee
14.3 The Most Used IVD Assays
14.4 The Highest Grossing Assays
14.5 Laboratory Fees Schedule
14.6 The Whole Genome Sequence of SARS-CoV-2

Table 1 The Base Pairs
Table 2 Most Common Traditional Genetic Disorders
Table 3 The Base Pairs
Table 4 List of GLOBAL SEQUENCING LOCATIONS
Table 5 Market Players by Type
Table 6 The Different Markets for Human Gene Sequencing
Table 7 DTC Sub Segments
Table 8 The Factors Driving Growth
Table 9 Factors Limiting Growth
Table 10 Six New Sequencing Technologies
Table 11 - Global Market by Region
Table 12 Global Market by Application
Table 13 Global Market by Technology
Table 14 Global Market by Workflow
Table 15 Global Market by Product
Table 16 Hereditary Segment by Country
Table 17 NIPT Segment by Country
Table 18 Oncology Segment by Country
Table 19 Psychology Segment by Country
Table 20 WGES Segment by Country
Table 21 Pharmacogenomics Segment by Country
Table 22 DTC Segment by Country
Table 23 Research Segment by Country
Table 24 Other Application Segment by Country
Table 25 Sanger Segment by Country
Table 26 NGS/2G Segment by Country
Table 27 3G/Long Segment by Country
Table 28 Other Technology by Country
Table 29 Sequencing Segment by Country
Table 30 Sample Prep Segment by Country
Table 31 Analysis Segment by Country
Table 32 Instruments Segment by Country
Table 33 Consumables Segment by Country
Table 34 Software & Services Segment by Country
Table 35 The Most Common Assays
Table 36 Largest Revenue Assays
Table 37 Clinical Lab Fee Schedule

Figure 1 Global Healthcare Spending
Figure 2 The Lab Test Pie
Figure 3 DNA Strands and Chromosomes
Figure 4 Karyogram of Human Chromosomes
Figure 5 Size of Various Genomes
Figure 6 Global Illumina Installed Base Map
Figure 7 The Road to Diagnostics
Figure 8 TruSight Germline Panel
Figure 9 Historical Cost of Gene Sequencing
Figure 10 - Cost To Sequence a Human Genome
Figure 11 Base Year Country Market Share Chart
Figure 12 Global Market by Application - Base vs. Final Year
Figure 13 Global Market by Application Base Year
Figure 14 Global Market by Application Final Year
Figure 15 Application Type Share by Year
Figure 16 by Application Segment Growth
Figure 17 Global Market by Technology - Base vs. Final Year
Figure 18 Global Market by Technology Base Year
Figure 19 Global Market by Technology Final Year
Figure 20 Technology Type Share by Year
Figure 21 by Technology Segment Growth
Figure 22 Global Market by Workflow - Base vs. Final Year
Figure 23 Global Market by Workflow Base Year
Figure 24 Global Market by Workflow Final Year
Figure 25 Workflow Type Share by Year
Figure 26 by Workflow Segment Growth
Figure 27 Global Market by Product - Base vs. Final Year
Figure 28 Global Market by Product Base Year
Figure 29 Global Market by Product Final Year
Figure 30 Product Type Share by Year
Figure 31 by Product Segment Growth
Figure 32 Hereditary vs. Total Market Growth
Figure 33 NIPT vs. Total Market Growth
Figure 34 Oncology vs. Total Market Growth
Figure 35 Psychology vs. Total Market Growth
Figure 36 WGES vs. Total Market Growth
Figure 37 Pharmacogenomics vs. Total Market Growth
Figure 38 DTC vs. Total Market Growth
Figure 39 Research vs. Total Market Growth
Figure 40 Other Application vs. Total Market Growth
Figure 41 Sanger vs. Total Market Growth
Figure 42 NGS/2G vs. Total Market Growth
Figure 43 3G/Long vs. Total Market Growth
Figure 44 Other Technology vs. Total Market Growth
Figure 45 Sequencing vs. Total Market Growth
Figure 46 Sample Prep vs. Total Market Growth
Figure 47 Analysis vs. Total Market Growth
Figure 48 Instruments vs. Total Market Growth
Figure 49 Consumables vs. Total Market Growth
Figure 50 Software & Services vs. Total Market Growth
Figure 51 IVD Test Menu Growth
Figure 52 IVD Test Average Fees - A Ten Year View